Australia markets closed

CanSino Biologics Inc. (6185.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
20.050+0.050 (+0.25%)
At close: 04:08PM HKT
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-1,513,280
-1,482,732
-909,431
1,914,390
-396,638
-
Depreciation & amortisation
-
269,053
196,360
88,542
31,817
-
Stock-based compensation
-
9,543
10,083
9,802
17,511
-
Change in working capital
-
-156,955
-1,478,956
55,164
-100,773
-
Inventory
-
-214,350
-604,019
-706,392
-144,157
-
Other working capital
-1,899,503
-1,526,722
-2,962,612
811,421
-740,163
-
Other non-cash items
-
-75,769
-199,509
-31,596
-3,102
-
Net cash provided by operating activities
-
-916,252
-1,887,599
2,014,557
-469,389
-
Cash flows from investing activities
Investments in property, plant and equipment
-529,650
-610,470
-1,075,013
-1,203,136
-270,774
-
Acquisitions, net
-
-110,038
-3,250
0
-
-
Purchases of investments
-8,104,313
-8,094,871
-12,361,495
-8,479,048
-6,287,010
-
Sales/maturities of investments
7,685,710
8,365,420
12,212,117
7,121,772
6,255,616
-
Other investing activities
1,063,377
8,025
35,686
29,142
119,455
-
Net cash used for investing activities
5,398
-441,622
-1,191,955
-2,531,270
-182,713
-
Net change in cash
-489,274
-1,365,456
-2,224,952
1,043,209
4,271,416
-
Cash at beginning of period
2,843,894
3,391,268
5,455,456
4,446,029
201,973
-
Cash at end of period
1,629,706
2,046,099
3,391,268
5,455,456
4,446,029
-
Free cash flow
Operating cash flow
-
-916,252
-1,887,599
2,014,557
-469,389
-
Capital expenditure
-529,650
-610,470
-1,075,013
-1,203,136
-270,774
-
Free cash flow
-1,899,503
-1,526,722
-2,962,612
811,421
-740,163
-